Document is current
Any future updates will be listed below
-
Authors
Lee, Michelle
Abousaud, Aseala
Harkins, R. Andrew
Marin, Ellen
Balasubramani, Deepali
Churnetski, Michael C.
Peker, Deniz
Singh, Ankur
Koff, Jean L. https://orcid.org/0000-0003-4414-0489
-
Funding
Funding for this research was provided by:
Lymphoma Research Foundation (611735)
National Cancer Institute (1R01CA266052)
- License Information
-
More Information
Article History
Accepted: 20 March 2023
First Online: 10 May 2023
Declarations
:
: Michelle Lee, Aseala Abousaud, R. Andrew Harkins, Ellen Marin, Deepali Balasubramani, Michael C. Churnetski, Deniz Peker, and Ankur Singh declare no conflict of interest. Jean L. Koff has received clinical trial funding from Atara Biotherapeutics, Oncternal Therapeutics, and Viracta Therapeutics; received research funding from Viracta Therapeutics; and received compensation for service as a consultant from TG Therapeutics, Gamida Cell, MorphoSys, AbbVie, and BeiGene.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
